Emerging opportunities for the treatment of inflammatory bowel disease

被引：0
|
作者：
Gale, JD [1 ]
McClure, KF
Pullen, N
机构：
[1] Pfizer Ltd, Global Res & Dev, Sandwich CT13 9NJ, Kent, England
[2] Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA
来源：
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38 | 2003年 / 38卷
关键词：
D O I：
10.1016/S0065-7743(03)38016-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：141 / 152
页数：12
相关论文
共 50 条
  • [21] Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease
    Sun, Donglei
    Li, Chenyang
    Chen, Shuang
    Zhang, Xiaolan
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [22] New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
    Danese, S.
    Angelucci, E.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 : S217 - S227
  • [23] Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?
    Fiorino, Gionata
    Rovida, Serena
    Correale, Carmen
    Malesci, Alberto
    Danese, Silvio
    CURRENT DRUG TARGETS, 2010, 11 (02) : 249 - 260
  • [24] Emerging Technologies in Inflammatory Bowel Disease A Minireview on Future Treatment Modalities
    Folsom, Madison R.
    Lightner, Amy L.
    SURGICAL CLINICS OF NORTH AMERICA, 2025, 105 (02) : 301 - 311
  • [25] Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
    Giuseppe Lippi
    Fabian Sanchis-Gomar
    World Journal of Gastroenterology, 2017, 23 (47) : 8283 - 8290
  • [26] Inflammatory Bowel Disease in Asia: The Challenges and Opportunities
    Hu, Pin-Jin
    INTESTINAL RESEARCH, 2015, 13 (03) : 188 - 190
  • [27] Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
    Lippi, Giuseppe
    Sanchis-Gomar, Fabian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (47) : 8283 - 8290
  • [28] Inflammatory bowel disease in India: challenges and opportunities
    Snell, Alice
    Segal, Jonathan
    Limdi, Jimmy
    Banerjee, Rupa
    FRONTLINE GASTROENTEROLOGY, 2021, 12 (05) : 390 - 396
  • [29] Telemedicine in Inflammatory Bowel Disease: Opportunities and Approaches
    Peris, Mariam Aguas
    Del Hoyo, Javier
    Bebia, Paloma
    Faubel, Raquel
    Barrios, Alejandra
    Bastida, Guillermo
    Valdivieso, Bernardo
    Nos, Pilar
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (02) : 392 - 399
  • [30] Emerging Significance of NLRs in Inflammatory Bowel Disease
    Davis, Beckley K.
    Philipson, Casandra
    Hontecillas, Raquel
    Eden, Kristin
    Bassaganya-Riera, Josep
    Allen, Irving C.
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (12) : 2412 - 2432
12345